Sumner Michael John 4
4 · INOVIO PHARMACEUTICALS, INC. · Filed May 21, 2025
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2025-05-20+28,350→ 28,350 total→ Common Stock (28,350 underlying) - Award
Common Stock Option
2025-05-20+35,100→ 35,100 totalExercise: $2.13Exp: 2035-05-20→ Common Stock (35,100 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 28,350 restricted stock units is as follows: 9,450 shares will vest on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]The vesting schedule for the 31,500 options is as follows: 17,550 shares will vest on May 20, 2027 and 17,550 shares will vest on May 20, 2028.